Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Biotech
Kailera launches with $400M series A, 4 Chinese obesity drugs
Kailera has launched into the increasingly crowded obesity space with a portfolio of assets acquired from China and $400 million in series A funds.
James Waldron
Oct 1, 2024 8:30am
Metsera allies with Amneal to lock down GLP-1 supply
Oct 1, 2024 6:01am
Biolexis enters small molecule into oral GLP-1 horse race
Sep 13, 2024 12:24pm
Lilly posts more positive data on once-weekly insulin prospect
Sep 11, 2024 2:05pm
Roche hopes obesity drug will show 25% weight loss one day
Sep 11, 2024 11:45am
Novo hails ‘remarkable’ weight loss result for experimental pill
Sep 11, 2024 11:02am